Rockline Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8M Buy
31,519
+22
+0.1% +$5.13K 1.53% 19
2026
Q1
$7.7M Sell
31,497
-527
-2% -$123K 1.67% 15
2025
Q4
$6.63M Buy
32,024
+622
+2% +$123K 1.35% 19
2025
Q3
$5.82M Sell
31,402
-102
-0.3% -$17.5K 1.21% 21
2025
Q2
$4.81M Buy
31,504
+400
+1% +$61.5K 1.14% 27
2025
Q1
$5.16M Buy
31,104
+1,139
+4% +$178K 1.44% 19
2024
Q4
$4.33M Buy
29,965
+1,553
+5% +$241K 1.16% 25
2024
Q3
$4.6M Buy
28,412
+801
+3% +$128K 1.3% 20
2024
Q2
$4.04M Buy
27,611
+808
+3% +$120K 1.25% 21
2024
Q1
$4.24M Buy
26,803
+488
+2% +$77.7K 1.48% 22
2023
Q4
$4.12M Buy
+26,315
New +$4.04M 1.71% 17

Other funds holding JNJ

Rockline Wealth Management's JNJ Position: Q2 2026 in Review

Rockline Wealth Management increased its Johnson & Johnson (JNJ) stake by 0.07% in Q2 2026, buying an estimated $5.13K and bringing the position to 31,519 shares worth $8M. The position accounts for 1.53% of the portfolio, ranked #19.

Rockline Wealth Management first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 4,650 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Rockline Wealth Management held 31,519 shares of Johnson & Johnson worth $8M as of Q2 2026.
  • Rockline Wealth Management bought 22 Johnson & Johnson shares in Q2 2026, an estimated $5.13K.
  • Johnson & Johnson made up 1.53% of Rockline Wealth Management's portfolio in Q2 2026, its #19 holding.
  • Rockline Wealth Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 4,650 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Rockline Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.